1. Home
  2. VERV vs BSVN Comparison

VERV vs BSVN Comparison

Compare VERV & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • BSVN
  • Stock Information
  • Founded
  • VERV 2018
  • BSVN 2004
  • Country
  • VERV United States
  • BSVN United States
  • Employees
  • VERV N/A
  • BSVN N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • BSVN Major Banks
  • Sector
  • VERV Health Care
  • BSVN Finance
  • Exchange
  • VERV Nasdaq
  • BSVN Nasdaq
  • Market Cap
  • VERV 475.0M
  • BSVN 438.8M
  • IPO Year
  • VERV 2021
  • BSVN 2018
  • Fundamental
  • Price
  • VERV $6.14
  • BSVN $44.40
  • Analyst Decision
  • VERV Strong Buy
  • BSVN Buy
  • Analyst Count
  • VERV 4
  • BSVN 3
  • Target Price
  • VERV $25.75
  • BSVN $46.00
  • AVG Volume (30 Days)
  • VERV 1.5M
  • BSVN 35.9K
  • Earning Date
  • VERV 02-25-2025
  • BSVN 01-16-2025
  • Dividend Yield
  • VERV N/A
  • BSVN 2.03%
  • EPS Growth
  • VERV N/A
  • BSVN 58.69
  • EPS
  • VERV N/A
  • BSVN 4.84
  • Revenue
  • VERV $24,396,000.00
  • BSVN $97,449,000.00
  • Revenue This Year
  • VERV $97.47
  • BSVN N/A
  • Revenue Next Year
  • VERV N/A
  • BSVN N/A
  • P/E Ratio
  • VERV N/A
  • BSVN $9.17
  • Revenue Growth
  • VERV 219.91
  • BSVN 37.95
  • 52 Week Low
  • VERV $4.31
  • BSVN $24.50
  • 52 Week High
  • VERV $19.34
  • BSVN $50.26
  • Technical
  • Relative Strength Index (RSI)
  • VERV 53.75
  • BSVN 47.87
  • Support Level
  • VERV $5.32
  • BSVN $41.50
  • Resistance Level
  • VERV $6.87
  • BSVN $50.26
  • Average True Range (ATR)
  • VERV 0.52
  • BSVN 1.78
  • MACD
  • VERV -0.00
  • BSVN -0.00
  • Stochastic Oscillator
  • VERV 56.74
  • BSVN 33.11

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a wide variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. it offers commercial real estate lending, hospitality lending, energy lending, and commercial and industrial lending, and also provides consumer lending services to individuals.

Share on Social Networks: